1. Home
  2. ALT vs RBB Comparison

ALT vs RBB Comparison

Compare ALT & RBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • RBB
  • Stock Information
  • Founded
  • ALT 1997
  • RBB 2008
  • Country
  • ALT United States
  • RBB United States
  • Employees
  • ALT N/A
  • RBB N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • RBB Major Banks
  • Sector
  • ALT Health Care
  • RBB Finance
  • Exchange
  • ALT Nasdaq
  • RBB Nasdaq
  • Market Cap
  • ALT 292.0M
  • RBB 335.4M
  • IPO Year
  • ALT N/A
  • RBB 2017
  • Fundamental
  • Price
  • ALT $3.67
  • RBB $20.51
  • Analyst Decision
  • ALT Strong Buy
  • RBB Hold
  • Analyst Count
  • ALT 6
  • RBB 3
  • Target Price
  • ALT $17.40
  • RBB $21.33
  • AVG Volume (30 Days)
  • ALT 2.8M
  • RBB 61.6K
  • Earning Date
  • ALT 08-12-2025
  • RBB 10-20-2025
  • Dividend Yield
  • ALT N/A
  • RBB 3.12%
  • EPS Growth
  • ALT N/A
  • RBB N/A
  • EPS
  • ALT N/A
  • RBB 1.30
  • Revenue
  • ALT $20,000.00
  • RBB $99,634,000.00
  • Revenue This Year
  • ALT N/A
  • RBB $18.56
  • Revenue Next Year
  • ALT $761,880.20
  • RBB $9.19
  • P/E Ratio
  • ALT N/A
  • RBB $15.80
  • Revenue Growth
  • ALT N/A
  • RBB N/A
  • 52 Week Low
  • ALT $2.90
  • RBB $14.40
  • 52 Week High
  • ALT $11.16
  • RBB $25.30
  • Technical
  • Relative Strength Index (RSI)
  • ALT 46.45
  • RBB 68.38
  • Support Level
  • ALT $3.35
  • RBB $19.30
  • Resistance Level
  • ALT $3.66
  • RBB $20.64
  • Average True Range (ATR)
  • ALT 0.18
  • RBB 0.44
  • MACD
  • ALT 0.05
  • RBB 0.11
  • Stochastic Oscillator
  • ALT 58.57
  • RBB 94.54

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About RBB RBB Bancorp

RBB Bancorp operates as a bank holding company. It provides various banking products and services such as checking, savings, money market accounts, and certificates of deposits. Its Specific services include remote deposit, E-banking, mobile banking, commercial and investor real estate loans, business loans and lines of credit, Small Business Administration (SBA) 7A and 504 loans, mortgage loans, trade finance, and a full range of depository accounts. It generates its revenue from interest received on loans and leases and, to a lesser extent, from interest received on investment securities and derives income from noninterest sources, such as fees received in connection with various lending and deposit services, loan servicing, gain on sales of loans, and wealth management services.

Share on Social Networks: